Meeting
2020 Gastrointestinal Cancers Symposium
Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
Authors
Ankita Tandon
Department of Internal Medicine, University of South Florida, Tampa, FL
Ankita Tandon , Jessica Frakes , Rutika Mehta , Sarah E. Hoffe , Maria E Martinez Jimenez , Iman Imanirad , Julian Sanchez , Mokenge Peter Malafa , Seth Felder , Sophie Dessureault , Richard D. Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT02935309
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 125)
Abstract #
125
Poster Bd #
F11
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Phase I study of preoperative capecitabine and lenvatinib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Jessica Frakes
Poster
2014 ASCO Annual Meeting
Phase I study of preoperative continuous 5-FU and sorafenib with external radiation therapy in locally advanced rectal adenocarcinoma.
First Author: Gopi Kesaria Prithviraj
Poster
2012 Gastrointestinal Cancers Symposium
Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial.
First Author: Prajnan Das
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang